You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation

Showing 1 - 25 of 5,115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

Recruiting
  • Neoplasms
  • Brno, Czechia
  • +20 more
Nov 21, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Fullerton, California
  • +192 more
Oct 17, 2022

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Solid Tumors Trial in Worldwide (Tislelizumab, Pamiparib)

Completed
Has Results
  • Solid Tumors
  • Scottsdale, Arizona
  • +28 more
Oct 27, 2021

Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)

Active, not recruiting
Has Results
  • Ovarian Neoplasms
  • Mobile, Alabama
  • +27 more
Nov 23, 2022

Bespoke ctDNA Assay for Recurrence and Treatment Response

Recruiting
  • Ovarian Cancer
  • platinum-sensitive EOC
  • platinum-resistant and rEOC
  • Shanghai, Shanghai, China
    Hao Wen
Jul 5, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)

Active, not recruiting
  • Metastatic Breast Cancer
  • PARP inhibitor 2X-121
  • Herlev, Denmark
  • +1 more
Feb 1, 2023

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Breast Cancer Trial in Worldwide (Neoadjuvant Olaparib monotherapy group, Neoadjuvant combination therapy with olaparib plus

Not yet recruiting
  • Breast Cancer
  • Neoadjuvant Olaparib monotherapy group
  • Neoadjuvant combination therapy with olaparib plus durvalumab
  • Wien, Austria
  • +6 more
Aug 10, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Biospecimen Collection
  • +4 more
  • Anchorage, Alaska
  • +357 more
Jan 28, 2023

Ovarian Cancer Recurrent Trial in Birmingham (M4344+Niraparib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jul 28, 2023

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

Recruiting
  • Ovarian Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 13, 2022

    Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

    Recruiting
    • Urothelial Cancer
    • Niraparib plus Cabozantinib
    • Barcelona, Cataluña, Spain
    • +10 more
    Feb 8, 2022

    Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

    Recruiting
    • Locally Advanced Leiomyosarcoma
    • +5 more
    • New York, New York
      Columbia University/Herbert Irving Cancer Center
    Jan 4, 2023

    Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

    Active, not recruiting
    • Breast Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 1, 2023

    Predictive Immune Biomarkers of Response to PAPR Inhibitors

    Recruiting
    • Ovarian Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Nov 25, 2022

      Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

      Not yet recruiting
      • Prostate Cancer
      • Castrate Resistant Prostate Cancer
      • Enzalutamide 40 MG
      • Docetaxel injection
      • (no location specified)
      Jan 27, 2023